Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| THFFFirst Financial Corp | $1.26B | 11.1× | $261.84M | +20.2% | $79.21M | $96.63M | $299.14M | Fair valued |
| DFHDream Finders Homes, Inc. | $1.26B | 9.8× | $4.32B | -2.9% | $217.2M | $203.49M | $1.82B | Fair valued |
| CDRECadre Holdings, Inc. | $1.26B | 34.8× | $610.31M | +7.5% | $44.14M | $53.98M | $399.83M | Fair valued |
| PSNYPolestar Automotive Holding UK PLC | $1.27B | — | $2.03B | -14.1% | -$2.05B | $718.63M | $4.06B | Overvalued |
| JBIOJade Biosciences, Inc. | $1.27B | — | — | — | — | $107.25M | $761K | Overvalued |
| VTOLBristow Group Inc. | $1.27B | 12.3× | $1.49B | +5.3% | $129.07M | $312.3M | $969.75M | Fair valued |
| LNNLindsay Corp | $1.27B | 23.9× | $659.07M | +12.8% | $74.05M | $154.76M | $137.83M | Overvalued |
| MLTXMoonLake Immunotherapeutics | $1.27B | — | — | — | — | $477.91M | $101.53M | Fair valued |
| HLFHerbalife Ltd. | $1.27B | 7.8× | $5.04B | +0.9% | $228.3M | $370.5M | $2.2B | Undervalued |
| PRCTPROCEPT BioRobotics Corp | $1.27B | — | $308.05M | +37.2% | -$95.57M | $227.91M | $77.5M | Fair valued |
| VYXNCR Voyix Corp | $1.27B | 22.6× | $2.69B | -4.6% | $62M | $237M | $1.31B | Undervalued |
| BJRIBJs RESTAURANTS INC | $1.28B | 32.0× | $1.4B | +3.1% | $48.81M | $14.43M | $434.66M | Overvalued |
| HLITHarmonic Inc. | $1.28B | — | $360.52M | -26.2% | -$43.31M | $231.86M | $130.12M | Fair valued |
| RCATRed Cat Holdings, Inc. | $1.28B | — | $40.73M | +4,494.7% | -$72.08M | $325.55M | $15.77M | Overvalued |
| TENTsakos Energy Navigation Ltd | $1.28B | 7.1× | $798.69M | -0.7% | $160.9M | $293.31M | $1.79B | Undervalued |
| PCTPureCycle Technologies, Inc. | $1.28B | — | $8.36M | — | -$182.57M | $165.22M | $67.94M | Fair valued |
| OPYOppenheimer Holdings Inc | $1.28B | 13.7× | $1.42B | +15.9% | $148.4M | $38.45M | $141.19M | Fair valued |
| SPTXSeaport Therapeutics, Inc. | $1.28B | — | — | — | — | $64.22M | $5.02M | Fair valued |
| IARTIntegra Lifesciences Holdings Corp | $1.28B | — | $1.64B | +1.5% | -$516.47M | $214.42M | $883.77M | Fair valued |
| MSDLMorgan Stanley Direct Lending Fund | $1.28B | 22.1× | $397.29M | -4.5% | $122.09M | $65.82M | $1.98B | Undervalued |